8020 Federal Register / Vol. 87, No. 29 / Friday, February 11, 2022 / Notices 

BURDEN REMAINING FROM PREVIOUSLY APPROVED INFORMATION COLLECTIONS

[Note: Data collection for the second follow-up is expected to be completed within the next year.] 

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request period) 

Average 

burden per 

response 

(in hours) 

Annual 

burden 

(in hours) 

Second follow-up survey ................................................................................. 824 1 0.75 618 

Estimated Total Annual Burden 

Hours: 618. 

NEW BURDEN REQUESTED

[Note: New data collection is expected to take place over about 3 years] 

Instrument 

Number of 

respondents 

(total over 

request period) 

Number of 

responses per 

respondent 

(total over 

request period) 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Annual 

burden 

(in hours) 

Third follow-up survey .......................................................... 4,239 1 0.75 3,179 1,060 

Semi-structured management interviews ............................ 20 1 1 20 7 

Semi-structured staff and supervisor interviews .................. 40 1 1 40 13 

Semi-structured participant interviews, MyGoals ................ 14 1 2.5 35 12 

Semi-structured participant interviews, LIFT ....................... 7 1 2 14 5 

Semi-structured participant interviews, FaDSS and Goal4 

It! ....................................................................................... 14 1 1.5 21 7 

Estimated Total Annual Burden 

Hours: 1,104. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 42 U.S.C. 613. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–02920 Filed 2–10–22; 8:45 am] 

BILLING CODE 4184–09–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Request for Public Comment: 60 Day 

Information Collection: Urban Indian 

Organization On-Site Review 

AGENCY: Indian Health Service, HHS. 

ACTION: Notice and request for 

comments. Request for approval. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Indian Health Service (IHS) invites the 

general public to comment on the 

information collection titled, ‘‘Urban 

Indian Organization On-Site Review,’’ 

Office of Management and Budget 

(OMB) Control Number 0917–00XX. IHS 

is requesting OMB to approve a new 

collection. 

DATES: Comment Due Date: April 12, 

2022. Your comments regarding this 

information collection are best assured 

of having full effect if received within 

60 days of the date of this publication. 

ADDRESSES: Send your written 

comments, requests for more 

information on the collection, or 

requests to obtain a copy of the data 

collection instrument and instructions 

to Shannon Beyale, Health System 

Specialist, by one of the following 

methods: 

• Mail: Indian Health Service, Office 

of Urban Indian Health Programs, 5600 

Fishers Lane, Mail Stop: 08E65D, 

Rockville, MD 20857. 

• Phone: 301–945–3657. 

• Email: Shannon.Beyale@ihs.gov. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

contact Evonne Bennett, Information 

Collection Clearance Officer at: 

Evonne.Bennett@ihs.gov or 301–443– 

4750. 

SUPPLEMENTARY INFORMATION: The 

Indian Health Care Improvement Act 

(IHCIA), at 25 U.S.C. 1655, states that 

the IHS will annually review and 

evaluate each Urban Indian 

Organization (UIO) funded under the 

law. The IHCIA also requires IHS to 

develop procedures for evaluating 

compliance with awards made under 

the statute. Section 1655 states, in part: 

(a) Contract Compliance and 

Performance 

The Secretary, through the Service, 

shall develop procedures to evaluate 

compliance with grant requirements 

under this subchapter and compliance 

with, and performance of contracts 

entered into by [UIOs] under this 

subchapter. Such procedures shall 

include provisions for carrying out the 

requirements of this section. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 29 / Friday, February 11, 2022 / Notices 8021 

(b) Annual Onsite Evaluation 

The Secretary, through the Service, 

shall conduct an annual on-site 

evaluation of each [UIO] which has 

entered into a contract or received a 

grant under Section 1653 of this title for 

purposes of determining the compliance 

of such organization with, and 

evaluating the performance of such 

organization under, such contract or the 

terms of such grant. 

To meet statutory compliance, the IHS 

will conduct annual on-site reviews of 

UIOs funded under the IHCIA to ensure 

grant and contract compliance and the 

delivery of safe and high-quality health 

care. 

This notice announces our intent to 

establish a new information collection. 

Title: Urban Indian Organization OnSite Review. Need and Use of 

Information Collection: The Office of 

Urban Indian Health Programs (OUIHP) 

at IHS Headquarters provides national 

oversight of the annual on-site reviews. 

The IHS Urban Indian Organization OnSite Review is conducted annually by 

the IHS Area Offices to evaluate IHSfunded Urban Indian Organizations 

compliance with Federal Acquisition 

Regulation (FAR) contractual 

requirements and grant requirements 

established through the IHCIA. The onsite review requirements are based on 

best-practice standards for delivering 

safe and high quality health care. 

Agency Form Number: none. Members 

of Affected Public: IHS-funded Urban 

Indian Organizations. Status of the 

Proposed Information Collection: new. 

The table below provides: Types of 

data collection instruments, Estimated 

number of respondents, Number of 

responses per respondent, Average 

burden hour per response, and Total 

annual burden hours. 

Data collection instrument(s) 

Estimated 

number of 

respondents 

Responses 

per 

respondent 

Average 

burden hour 

per response * 

Total annual 

burden hours 

UIOs ................................................................................................................. 41 1 16 656 

Total .......................................................................................................... 41 1 16 656 

There are no direct costs to 

respondents to report. 

Requests for Comments: Your written 

comments and/or suggestions are 

invited on one or more of the following 

points: 

(a) Whether the information collection 

activity is necessary to carry out an 

agency function; 

(b) whether the agency processes the 

information collected in a useful and 

timely fashion; 

(c) the accuracy of the public burden 

estimate (the estimated amount of time 

needed for individual respondents to 

provide the requested information); 

(d) whether the methodology and 

assumptions used to determine the 

estimates are logical; 

(e) ways to enhance the quality, 

utility, and clarity of the information 

being collected; and 

(f) ways to minimize the public 

burden through the use of automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Elizabeth A. Fowler, 

Acting Deputy Director, Indian Health 

Service. 

[FR Doc. 2022–02969 Filed 2–10–22; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Endocrinology, Metabolism, 

Nutrition and Reproductive Sciences. 

Date: March 11, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Baskaran Thyagarajan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 800B, 

Bethesda, MD 20892, (301) 867–5309, 

thyagarajanb2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; NIH 

Director New Innovator Award Program 

(DP2). 

Date: March 15–16, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Contact Person: Imoh S. Okon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, 301–347–8881, imoh.okon@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Biobehavioral and Behavioral 

Processes. 

Date: March 15, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pablo M. Blazquez Gamez, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, 

pablo.blazquezgamez@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Diagnostics and Treatments 

(CDT). 

Date: March 21–22, 2022. 

Time: 9:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Victor A. Panchenko, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 802B2, 

Bethesda, MD 20892, victor.panchenko@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery and Development. 

Date: March 21–22, 2022. 

Time: 10:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 


lotter on DSK11XQN23PROD with NOTICES1